These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 30513818)

  • 21. Elevated urinary levels of 8-oxo-2'-deoxyguanosine, (5'R)- and (5'S)-8,5'-cyclo-2'-deoxyadenosines, and 8-iso-prostaglandin F
    Kant M; Akış M; Çalan M; Arkan T; Bayraktar F; Dizdaroglu M; İşlekel H
    DNA Repair (Amst); 2016 Dec; 48():1-7. PubMed ID: 27769710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial.
    Guo W; Tian W; Lin L; Xu X
    Diabetes Res Clin Pract; 2020 Dec; 170():108487. PubMed ID: 33035599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study.
    Vadini F; Simeone PG; Boccatonda A; Guagnano MT; Liani R; Tripaldi R; Di Castelnuovo A; Cipollone F; Consoli A; Santilli F
    Int J Obes (Lond); 2020 Jun; 44(6):1254-1263. PubMed ID: 31965072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis.
    Di Minno MN; Pezzullo S; Palmieri V; Coppola A; D'Angelo A; Sampietro F; Cavalca V; Tremoli E; Di Minno G
    Thromb Res; 2011 Oct; 128(4):e43-8. PubMed ID: 21669453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress and platelet activation in homozygous homocystinuria.
    Davì G; Di Minno G; Coppola A; Andria G; Cerbone AM; Madonna P; Tufano A; Falco A; Marchesani P; Ciabattoni G; Patrono C
    Circulation; 2001 Sep; 104(10):1124-8. PubMed ID: 11535567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost.
    Lessiani G; Vazzana N; Cuccurullo C; Di Michele D; Laurora G; Sgrò G; Di Ruscio P; Simeone E; Di Iorio P; Lattanzio S; Liani R; Ferrante E; Davì G
    Thromb Haemost; 2011 Feb; 105(2):321-8. PubMed ID: 21103664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D-galactose induced inflammation lipid peroxidation and platelet activation in rats.
    Hadzi-Petrushev N; Stojkovski V; Mitrov D; Mladenov M
    Cytokine; 2014 Sep; 69(1):150-3. PubMed ID: 24907931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of chronic chromium exposition on the processes of lipid peroxidation inflammation and platelet activation in rats.
    Mitrov D; Hadzi-Petrushev N; Stojkovski V; Gjorgievska E; Gagov H; Mladenov M
    J Biol Regul Homeost Agents; 2014; 28(3):531-5. PubMed ID: 25316141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus.
    De Cristofaro R; Rocca B; Vitacolonna E; Falco A; Marchesani P; Ciabattoni G; Landolfi R; Patrono C; Davì G
    J Thromb Haemost; 2003 Feb; 1(2):250-6. PubMed ID: 12871497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exposure-response analyses of liraglutide 3.0 mg for weight management.
    Wilding JP; Overgaard RV; Jacobsen LV; Jensen CB; le Roux CW
    Diabetes Obes Metab; 2016 May; 18(5):491-9. PubMed ID: 26833744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidant stress as a major determinant of platelet activation in invasive breast cancer.
    Ferroni P; Santilli F; Cavaliere F; Simeone P; Costarelli L; Liani R; Tripaldi R; Riondino S; Roselli M; Davi G; Guadagni F
    Int J Cancer; 2017 Feb; 140(3):696-704. PubMed ID: 27784132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Liraglutide Monotherapy on Beta Cell Function and Pancreatic Enzymes Compared with Metformin in Japanese Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Subpopulation Analysis of the KIND-LM Randomized Trial.
    Tanaka K; Saisho Y; Manesso E; Tanaka M; Meguro S; Irie J; Sugiura H; Kawai T; Jinzaki M; Cobelli C; Itoh H;
    Clin Drug Investig; 2015 Oct; 35(10):675-84. PubMed ID: 26369653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.
    Yan J; Yao B; Kuang H; Yang X; Huang Q; Hong T; Li Y; Dou J; Yang W; Qin G; Yuan H; Xiao X; Luo S; Shan Z; Deng H; Tan Y; Xu F; Xu W; Zeng L; Kang Z; Weng J
    Hepatology; 2019 Jun; 69(6):2414-2426. PubMed ID: 30341767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetes.
    Tanaka K; Saisho Y; Kawai T; Tanaka M; Meguro S; Irie J; Imai T; Shigihara T; Morimoto J; Yajima K; Atsumi Y; Takei I; Itoh H
    Endocr J; 2015; 62(5):399-409. PubMed ID: 25739726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists.
    Cuthbertson DJ; Irwin A; Gardner CJ; Daousi C; Purewal T; Furlong N; Goenka N; Thomas EL; Adams VL; Pushpakom SP; Pirmohamed M; Kemp GJ
    PLoS One; 2012; 7(12):e50117. PubMed ID: 23236362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study.
    Cesari M; Kritchevsky SB; Nicklas B; Kanaya AM; Patrignani P; Tacconelli S; Tranah GJ; Tognoni G; Harris TB; Incalzi RA; Newman AB; Pahor M;
    J Gerontol A Biol Sci Med Sci; 2012 Jun; 67(6):671-6. PubMed ID: 22389462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of platelet activation in human essential hypertension.
    Minuz P; Patrignani P; Gaino S; Seta F; Capone ML; Tacconelli S; Degan M; Faccini G; Fornasiero A; Talamini G; Tommasoli R; Arosio E; Santonastaso CL; Lechi A; Patrono C
    Hypertension; 2004 Jan; 43(1):64-70. PubMed ID: 14656953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance as a determinant of platelet activation in obese women.
    Basili S; Pacini G; Guagnano MT; Manigrasso MR; Santilli F; Pettinella C; Ciabattoni G; Patrono C; Davì G
    J Am Coll Cardiol; 2006 Dec; 48(12):2531-8. PubMed ID: 17174194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.